Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01360645 Completed - Depression Clinical Trials

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Pyxis
Start date: July 2011
Phase: Phase 3
Study type: Interventional

To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo (an inactive substance) as add on treatment to an assigned FDA approved antidepressant treatment (ADT) in patients with Major Depressive Disorder who demonstrate an incomplete response to a prospective trial of the same assigned FDA approved ADT

NCT ID: NCT01360632 Completed - Depression Clinical Trials

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Polaris
Start date: June 2011
Phase: Phase 3
Study type: Interventional

To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo (an inactive substance) as add on treatment to an assigned FDA approved antidepressant treatment (ADT) in patients with Major Depressive Disorder who demonstrate an incomplete response to a prospective trial of the same assigned FDA approved ADT

NCT ID: NCT01357083 Completed - Clinical trials for Major Depressive Disorder

The Study of Serum Melatonin Rhythm Levels in Patients With Major Depressive Disorder

Start date: August 2010
Phase: N/A
Study type: Observational

One of the main points in the biological trends is, the circadian rhythm and disturbance in this cycle, which cause mood disorders and irregularity in this bio clock, to get depression. The pineal gland with the precise regulation of circadian rhythm of melatonin regulates the brain haemostasis. The abnormal function of this gland gives rise to psychiatric disorders. In the period of youth and early of middle-age cause biochemical changes and disturbance in biorhythm including melatonin secretion. This process can change the peak of melatonin phase. In addition, a decrease in the level of serum melatonin, can change the function of immune system of depressed patients. This function facilitates the process of cancerous cell formation and tumor growth. With respect to the conflicting results and that the positive and negative roles of melatonin in the creation of depression is unknown, the aim of this study was to compare the morning and nocturnal serum melatonin rhythm levels in the patients with Major Depressive Disorder. The second purpose was to measure the morning and nocturnal serum melatonin levels in the depressed and healthy men and women.

NCT ID: NCT01354236 Enrolling by invitation - Anxiety Disorders Clinical Trials

Mental Health Related to School Dropout in Luxembourg

Start date: January 2011
Phase: N/A
Study type: Observational

This study aims to investigate psychosocial risk- and protective factors such as psychiatric disorder, socio-economic background and family functioning among school dropouts and to compare the findings with those by a matched control group of regularly enrolled students.

NCT ID: NCT01350986 Recruiting - Clinical trials for Oppositional Defiant Disorder

Guided Self-Help for Parents of Children With Externalizing Problem Behavior

FLOH
Start date: May 2011
Phase: N/A
Study type: Interventional

The efficacy of cognitive-behavioral based guided self-help for parents of children with externalizing problem behavior is tested in a randomized clinical trial. Parents work through cognitive-behavioral self-help booklets and additionally receive counseling telephone calls every two weeks. In the control condition parents are provided non-directive self-help booklets and additionally receive counseling telephone calls. It is hypothesized that the cognitive-behavioral treatment is superior.

NCT ID: NCT01350375 Completed - Clinical trials for Forward Head Posture With Associated Episodic Headache Disorder

Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study will investigate the therapeutic utility of BOTOX in reducing the degree of Forward Head Posture (FHP) with associated headache and myofascial pain, decreasing the frequency of headache, and improving the overall quality of life.

NCT ID: NCT01349751 Completed - Clinical trials for Observation of Neuromuscular Block

Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution

Start date: January 2007
Phase: N/A
Study type: Interventional

The authors would like to investigate the blocking characteristics, surgical quality and side effects of intrathecal levobupivacaine whether there are any differences between the hyperbaric and the isobaric formulation for gynaecologic surgeries which need higher block level than the urological surgeries.

NCT ID: NCT01348529 Completed - Clinical trials for Obsessive Compulsive Disorder

Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)

Start date: September 2010
Phase: N/A
Study type: Interventional

The main aim of this study is to test whether cognitive behavior therapy could be effective in treating obsessive compulsive disorder. Here, the investigators test the in group effects of a 15 week long treatment delivered via the Internet for residents in Stockholm County.

NCT ID: NCT01347099 Completed - Clinical trials for Obsessive Compulsive Disorder

Internet-based Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)

Start date: February 2011
Phase: Phase 2
Study type: Interventional

Cognitive behavior therapy (CBT) is an effective treatment for obsessive compulsive disorder (OCD) but there is a lack of properly trained CBT therapists. One possible treatment alternative is Internet-based CBT (ICBT) with minimal therapist input. The aim of this study was therefore to evaluate ICBT for OCD.

NCT ID: NCT01347073 Completed - Clinical trials for Urea Cycle Disorders

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

Start date: July 2011
Phase: Phase 3
Study type: Interventional

This non-randomized, open-label study was approximately one year in duration and consisted of a short term NaPBA to HPN-100 switchover part involving two overnight stays followed by a 12-month long term treatment period involving monthly visits.